What is the share price of Krishna Institute of Medical Sciences Ltd (KIMS) today?
The share price of KIMS as on 4th November 2026 is ₹740.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Krishna Institute of Medical Sciences Ltd (KIMS) share?
The past returns of Krishna Institute of Medical Sciences Ltd (KIMS) share are- Past 1 week: 6.40%
- Past 1 month: 1.45%
- Past 3 months: -6.35%
- Past 6 months: 9.10%
- Past 1 year: 3.98%
- Past 3 years: 100.34%
- Past 5 years: 221.20%
What are the peers or stocks similar to Krishna Institute of Medical Sciences Ltd (KIMS)?
The peers or stocks similar to Krishna Institute of Medical Sciences Ltd (KIMS) include:What is the market cap of Krishna Institute of Medical Sciences Ltd (KIMS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹31103.58 Cr as of 4th November 2026.What is the 52 week high and low of Krishna Institute of Medical Sciences Ltd (KIMS) share?
The 52-week high of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹858 and the 52-week low is ₹575.80.What is the PE and PB ratio of Krishna Institute of Medical Sciences Ltd (KIMS) stock?
The P/E (price-to-earnings) ratio of Krishna Institute of Medical Sciences Ltd (KIMS) is 125.40. The P/B (price-to-book) ratio is 12.16.Which sector does Krishna Institute of Medical Sciences Ltd (KIMS) belong to?
Krishna Institute of Medical Sciences Ltd (KIMS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Krishna Institute of Medical Sciences Ltd (KIMS) shares?
You can directly buy Krishna Institute of Medical Sciences Ltd (KIMS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Krishna Institute of Medical Sciences Ltd
KIMS Share Price
NSEKIMS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
KIMS Performance & Key Metrics
KIMS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 152.24 | 12.16 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.84 | 5.87 | 0.49% |
from 15 analysts
Price Upside
Earnings Growth
Rev. Growth
KIMS Company Profile
Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.
KIMS Sentiment Analysis
KIMS Sentiment Analysis
KIMS Stock Summary · August 2026
Management struck a strongly constructive tone, saying the quarter extended a powerful growth run as revenue crossed the INR 1,000 crore mark and reached INR 1,196 crore, up 36.1% year over year, while EBITDA rose 20.1% to INR 240 crore with margin broadly steady at 20.1%. They linked the performance to robust demand across the hospital network, with double-digit inpatient and outpatient volume growth and improving revenue per bed and per patient, while also acknowledging that profitability lagged topline expansion, as PAT fell to INR 37 crore from INR 85 crore a year earlier. Balance-sheet repair was another priority, with the oversubscribed INR 1,500 crore QIP used to cut debt to about INR 2,400 crore from INR 3,250 crore. Management also highlighted the rapid ramp-up of new units, especially Kondapur and Mahadevapura, and said Kerala remains in a growth phase with near-term EBITDA margins in single digits before improving to mid-teens next fiscal year. Looking ahead, they said expansion will stay focused on core geographies and on stabilizing recent openings before pursuing additional greenfield opportunities.
KIMS Stock Growth Drivers
KIMS Stock Growth Drivers
8Strong Revenue and EBITDA Growth
The company delivered a very strong start to FY27, with revenue crossing the INR 1,000
Healthy Operating Demand and Volume Expansion
Underlying demand remained robust across the network, with both inpatient and outpatient activity growing strongly.
KIMS Stock Challenges
KIMS Stock Challenges
3Lower profitability despite strong revenue growth
The company delivered robust top-line and EBITDA growth, but bottom-line performance weakened materially. PAT fell
Temporary drag from the old Kondapur hospital
The legacy Kondapur facility continues to weigh on results because it is still operating for
KIMS Forecast
KIMS Forecasts
Price
Revenue
Earnings
KIMS Share Price Forecast
KIMS Share Price Forecast
All values in ₹
All values in ₹
KIMS Company Revenue Forecast
KIMS Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
KIMS Stock EPS (Earnings Per Share) Forecast
KIMS Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
KIMS
KIMS
Income
Balance Sheet
Cash Flow
KIMS Income Statement
KIMS Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 637.60 | 693.00 | 782.30 | 790.20 | 812.20 | 878.70 | 964.90 | 1,002.90 | 1,086.90 | 1,196.90 | ||||||||||
| Operating & Other expenses | 474.90 | 509.00 | 559.20 | 585.20 | 598.90 | 679.00 | 757.00 | 798.80 | 879.00 | 956.10 | ||||||||||
| EBITDA | 162.70 | 184.00 | 223.10 | 205.00 | 213.30 | 199.70 | 207.90 | 204.10 | 207.90 | 240.80 | ||||||||||
| Depreciation/Amortization | 46.30 | 39.00 | 41.00 | 44.70 | 52.60 | 53.40 | 66.10 | 78.70 | 85.00 | 100.80 | ||||||||||
| PBIT | 116.40 | 145.00 | 182.10 | 160.30 | 160.70 | 146.30 | 141.80 | 125.40 | 122.90 | 140.00 | ||||||||||
| Interest & Other Items | 16.40 | 17.90 | 19.90 | 25.70 | 26.70 | 32.60 | 45.00 | 56.80 | 68.10 | 83.40 | ||||||||||
| PBT | 100.00 | 127.10 | 162.20 | 134.60 | 134.00 | 113.70 | 96.80 | 68.60 | 54.80 | 56.60 | ||||||||||
| Taxes & Other Items | 34.50 | 40.50 | 54.80 | 45.90 | 32.20 | 35.10 | 29.90 | 15.20 | 12.30 | 15.10 | ||||||||||
| Net Income | 65.50 | 86.60 | 107.40 | 88.70 | 101.80 | 78.60 | 66.90 | 53.40 | 42.50 | 41.50 | ||||||||||
| EPS | 1.64 | 2.16 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 | 1.04 |
KIMS Company Updates
Investor Presentation
KIMS Stock Peers
KIMS Past Performance & Peer Comparison
KIMS Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krishna Institute of Medical Sciences Ltd | 125.40 | 12.16 | — |
| Apollo Hospitals Enterprise Limited | 62.82 | 12.39 | 0.23% |
| Max Healthcare Institute Limited | 60.81 | 8.40 | 0.22% |
| Manipal Health Enterprises Limited | 92.38 | 9.97 | — |
KIMS Stock Price Comparison
Compare KIMS with any stock or ETFKIMS Holdings
KIMS Shareholdings
KIMS Promoter Holdings Trend
KIMS Promoter Holdings Trend
In last 6 months, promoter holding in the company has decreased by 1.45%
Pledged promoter holdings is insignificant
KIMS Institutional Holdings Trend
KIMS Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
KIMS Shareholding Pattern
KIMS Shareholding Pattern
KIMS Shareholding History
KIMS Shareholding History
Mutual Funds Invested in KIMS
Mutual Funds Invested in KIMS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Krishna Institute of Medical Sciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.7085% | Percentage of the fund’s portfolio invested in the stock 2.04% | Change in the portfolio weight of the stock over the last 3 months -0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/88 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.6760% | Percentage of the fund’s portfolio invested in the stock 2.00% | Change in the portfolio weight of the stock over the last 3 months -0.50% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 42/80 (-33) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4646% | Percentage of the fund’s portfolio invested in the stock 2.46% | Change in the portfolio weight of the stock over the last 3 months -0.34% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 2/141 (0) |
Compare 3-month MF holding change on Screener
smallcases containing KIMS stock
smallcases containing KIMS stock
Looks like this stock is not in any smallcase yet.
KIMS Events
KIMS Events
KIMS Dividend Trend
KIMS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
KIMS Dividend Trend
KIMS has not given any dividends in last 5 years
KIMS Dividends
KIMS Dividends
KIMS Stock News & Opinions
KIMS Stock News & Opinions
Krishna Institute of Medical Sciences Limited has approved a scheme of amalgamation with its wholly-owned subsidiary, KIMS Hospitals Private Limited, according to a regulatory filing on Thursday. The merger, which will simplify the group's corporate structure and eliminate multiple legal entities, was recommended by the company's audit committee and is expected to optimize asset utilization and reduce compliance costs. KIMS Hospitals Private Limited has a paid-up capital of Rs 65,99,99,990, while Krishna Institute of Medical Sciences Limited has a paid-up capital of Rs 84,00,12,968.
Krishna Institute of Medical Sciences Limited announced the re-appointment of Dr. Abhinay Bollineni as Director & CEO for a further term of 5 years, Dr. Bhaskara Rao Bollineni as Chairman & Managing Director for a further term of five years including continuation beyond the age of 70 years, and Ms. Dandamudi Anitha as Whole-time Director for a term of 5 years, effective January 18, 2027, and April 1, 2027, respectively.
Krishna Institute of Medical Sciences Limited (KIMS) has entered into definitive agreements to acquire a 51% equity stake in Sarvottam Health Care Private Limited, Kakinada, for an aggregate consideration of up to Rs 80.00 crore. The acquisition, which does not constitute a related party transaction, is being made as a strategic investment and will be completed in due course, with KIMS remitting the consideration based on a valuation report from BDO Valuation Advisory LLP. Sarvottam Health Care Private Limited, operating as Trust Multi Speciality Hospital, has a turnover of Rs 84.83 crore for fiscal year 2025-26 and is located in Kakinada, Andhra Pradesh.
Krishna Institute of Medical Sciences Limited (KIMS) has acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for an aggregate consideration of Rs 15.00 crore, the company announced on Tuesday. The acquisition, described as a strategic investment, was based on a valuation report issued by BDO Valuation Advisory LLP and involved a primary infusion of capital. Ushahkal Abhinav Specialty Hospital LLP, founded in 2022, is a quaternary care facility with a current capacity of 316 beds and potential for expansion to over 500 beds, and reported a turnover of Rs 80.42 crore for fiscal year 2025-26.
Krishna Institute of Medical Sciences Limited will hold a board meeting on Wednesday, November 04, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026, according to a regulatory filing with the Bombay Stock Exchange and the National Stock Exchange. The company has closed the trading window for its equity shares for designated persons from October 01, 2026, until 48 hours after the financial results are made public.
Krishna Institute of Medical Sciences Limited submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, as received from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, its Registrar and Share Transfer Agent.
Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of an equity stake in Splendid Hospitals Private Limited (Kompally) for up to Rs 40.00 crore via primary infusion. The acquisition, which does not constitute a related party transaction, will see Krishna Institute of Medical Sciences acquire up to 22% of equity shares in Splendid Hospitals, a healthcare entity based in Kompally, Telangana, with the potential to expand to over 225 beds. The acquisition is expected to be completed on or before March 31, 2027, based on a valuation report from BDO Valuation Advisory LLP.
Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of up to 51% equity stake in Sarvottam Health Care Private Limited (Kakinada) for an investment of up to Rs 80.00 crore, with the acquisition expected to be completed on or before October 31, 2026. Sarvottam Health Care Private Limited, operating as Trust Multi Speciality Hospital in Kakinada, Andhra Pradesh, commenced operations in 2010 and currently has a capacity of 183 beds, with a turnover of Rs 84.83 crore in fiscal year 2026.
Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited (KIMS-SIKHARA), an operations and management entity, for a cash consideration of Rs 30.35 per equity share. The acquisition, which is expected to be completed within 12 to 24 months, will be executed as a strategic investment and does not fall under related party transactions. Insignia Healthcare Private Limited, incorporated in 2018 and based in Guntur, Andhra Pradesh, reported a turnover of Rs 104.5 crore in fiscal year 2025.
Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for up to Rs 15 crore via primary infusion, on or before October 31, 2026. The acquisition, based on a valuation report by BDO Valuation Advisory LLP, will see KIMS manage and operate the 316-bed quaternary care facility, branded as “KIMS-UAIMS,” which was founded in 2022 and is located in Sangli, Maharashtra. Ushahkal Abhinav Specialty Hospital LLP reported a turnover of Rs 80.42 crore for fiscal year 2025-26.
Over the last 5 years, revenue has grown at a yearly rate of 24.03%, vs industry avg of 17.91%
Over the last 5 years, market share increased from 3.05% to 3.77%
Over the last 5 years, net income has grown at a yearly rate of 3.71%, vs industry avg of 62.46%